These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 1829631

  • 21. Qualitative description of factors involved in the retraction and lysis of dilute whole blood clots and in the aggregation and retraction of platelets.
    Taylor FB, Müller-Eberhard HJ.
    J Clin Invest; 1970 Nov; 49(11):2068-85. PubMed ID: 4248913
    [Abstract] [Full Text] [Related]

  • 22. Fibrinogen Milano. VI: A heterozygous dysfibrinogenemia (A alpha 16 Arg----His) with bleeding tendency.
    Bögli C, Cofrancesco E, Cortellaro M, Della Volpe A, Hofer A, Furlan M, Zanussi C.
    Eur J Haematol; 1990 Jul; 45(1):26-30. PubMed ID: 2379562
    [Abstract] [Full Text] [Related]

  • 23. Fibrinogen Kawaguchi: an abnormal fibrinogen characterized by defective release of fibrinopeptide A.
    Matsuda M, Saeki E, Kasamatsu A, Nakamikawa C, Manabe S, Samejima Y.
    Thromb Res; 1985 Feb 01; 37(3):379-90. PubMed ID: 3992527
    [Abstract] [Full Text] [Related]

  • 24. Fibrinogen Barcelona I. Congenital dysfibrinogenemia characterized by defective release of fibrinopeptide A and fibrinogen degradation products.
    Vila V, Regañón E, Aznar J, Navarro G, Salas M.
    Thromb Res; 1987 Mar 01; 45(5):437-49. PubMed ID: 2954261
    [Abstract] [Full Text] [Related]

  • 25. Mechanism of ancrod anticoagulation. A direct proteolytic effect on fibrin.
    Pizzo SV, Schwartz ML, Hill RL, McKee PA.
    J Clin Invest; 1972 Nov 01; 51(11):2841-50. PubMed ID: 4263497
    [Abstract] [Full Text] [Related]

  • 26. Dysfibrinogenemia associated with liver disease.
    Palascak JE, Martinez J.
    J Clin Invest; 1977 Jul 01; 60(1):89-95. PubMed ID: 874092
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Molecular basis of fibrinogen Naples associated with defective thrombin binding and thrombophilia. Homozygous substitution of B beta 68 Ala----Thr.
    Koopman J, Haverkate F, Lord ST, Grimbergen J, Mannucci PM.
    J Clin Invest; 1992 Jul 01; 90(1):238-44. PubMed ID: 1634610
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Removal of extraplatelet Na+ eliminates indomethacin-sensitive secretion from human platelets stimulated by epinephrine, ADP, and thrombin.
    Connolly TM, Limbird LE.
    Proc Natl Acad Sci U S A; 1983 Sep 01; 80(17):5320-4. PubMed ID: 6577431
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Fibrinogen Milano XII: a dysfunctional variant containing 2 amino acid substitutions, Aalpha R16C and gamma G165R.
    Bolliger-Stucki B, Lord ST, Furlan M.
    Blood; 2001 Jul 15; 98(2):351-7. PubMed ID: 11435303
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Dysfibrinogenaemia characterized by abnormal fibrin monomer polymerization and normal fibrinopeptide A release.
    Lane DA, Cuddigan B, VanRoss M, Kakkar VV.
    Br J Haematol; 1980 Mar 15; 44(3):483-94. PubMed ID: 6769460
    [Abstract] [Full Text] [Related]

  • 38. Fibrinopeptide A cleavage and platelet release in whole blood in vitro. Effects of stimuli, inhibitors, and agitation.
    Kaplan KL, Drillings M, Lesznik G.
    J Clin Invest; 1981 May 15; 67(5):1561-8. PubMed ID: 6453136
    [Abstract] [Full Text] [Related]

  • 39. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis.
    Stucki B, Schmutz P, Schmid L, Haeberli A, Lämmle B, Furlan M.
    Thromb Haemost; 1999 Feb 15; 81(2):268-74. PubMed ID: 10064005
    [Abstract] [Full Text] [Related]

  • 40. A new congenital abnormal fibrinogen Ise characterized by the replacement of B beta glycine-15 by cysteine.
    Yoshida N, Wada H, Morita K, Hirata H, Matsuda M, Yamazumi K, Asakura S, Shirakawa S.
    Blood; 1991 May 01; 77(9):1958-63. PubMed ID: 2018836
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.